For more information...

For more information about the study and farletuzumab, please call
877-FAR-1311 (877-327-1311).

For a list of all participating sites with contact information, please visit: ClinicalTrials.gov

You may wish to consider taking advantage of additional resources and support services* available to you, including:

• Cancer Information Service
  1-800-4-CANCER (1-800-422-6237)
  TTY (deaf and hard of hearing callers): 1-800-332-8615
  
  
• National Cancer Institute
  
  
• Ovarian Cancer National Alliance
  
  
• National Ovarian Cancer Coalition

More information about clinical research studies can be found at www.cancer.gov/clinicaltrials/learning and www.cancer.gov/clinicaltrials/resources/clinical-trials-education-series.

 

Healthcare Practitioners/Potential Study Sites: Please contact us directly.

 

*These sources should be used for informational purposes only. If you have a health-related problem, please consult a doctor.

 

Thank you for your interest in the FAR-131 study. At this time we are no longer recruiting patients for this study.